Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 12 member 1 (SLC12A1), commonly known as NKCC2, is a kidney-specific symporter located on the apical membrane of the thick ascending limb of the loop of Henle [4, 9, 10]. It plays a pivotal role in renal physiology by mediating the electroneutral reabsorption of one sodium, one potassium, and two chloride ions from the tubular lumen into the epithelial cells [9, 14, 15]. This process accounts for approximately 20-25% of the total filtered sodium chloride and is essential for the generation of the medullary osmotic gradient required for urine concentration [14, 15, 19]. NKCC2 also functions as a sensor in the macula densa to regulate the tubuloglomerular feedback mechanism and renin secretion [12, 15]. Clinically, NKCC2 is the primary target of loop diuretics such as furosemide, which compete for the chloride-binding site to inhibit ion transport, thereby promoting diuresis and natriuresis [1, 5, 7]. These drugs are widely used to manage hypertension and edematous states associated with heart failure, cirrhosis, and renal disease [5, 7, 12]. Loss-of-function mutations in the SLC12A1 gene lead to Bartter syndrome type I, a severe salt-wasting disorder characterized by hypokalemia and metabolic alkalosis [4, 13, 16].
Inhibition of the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle by competing for the chloride-binding site, which prevents the reabsorption of sodium, potassium, and chloride ions.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 12 member 1 (SLC12A1) (NKCC2).